1-Methoxy-4-(2-propenyl)benzene



Compound IDCDAMM00801
Common name1-Methoxy-4-(2-propenyl)benzene
IUPAC name1-methoxy-4-prop-2-enylbenzene
Molecular formulaC10H12O

Experimental data

Retention time18.36
Adduct[M+H]+
Actual mz149.096
Theoretical mz149.096
Error1.5
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.422

Identifiers and class information

Inchi keyZFMSMUAANRJZFM-UHFFFAOYSA-N
SmilesO(C1=CC=C(C=C1)CC=C)C
SuperclassBenzenoids
ClassPhenol ethers

Pharmacokinetic properties

Number of descriptor values(#stars)4
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)3
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)1
Molecular weight (mol_MW)148.204
Computed dipole moment(dipole)1.337
Total solvent accessible surface area (SASA)389.224
Hydrophobic component of SASA (FOSA)204.013
Hydrophilic component of SASA (FISA)0
Pie component of the SASA (PISA)185.211
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)617.124
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)0.75
Free energy of solvation of dipole (dip^2/V)0.0028961
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.900632
Predicted polarizability in cubic angstroms (QPpolrz)18.386
Predicted hexadecane/gas partition coefficient (QPlogPC16)5.261
Predicted octanol/gas partition coefficient (QPlogPoct)5.469
Predicted water/gas partition coefficient (QPlogPw)1.993
Predicted octanol/water partition coefficient (QPlogPo/w)2.577
Predicted aqueous solubility (QPlogS)-3.209
Conformation-independent predicted aqueous solubility (CIQPlogS)-3.596
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.023
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)9906.04
Predicted brain/blood partition coefficient (QPlogBB)0.258
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)5899.29
Predicted skin permeability, log Kp (QPlogKp)-0.579
PM3 calculated ionization potential (IP(ev))9.008
PM3 calculated electron affinity (EA(eV))-0.329
Number of likely metabolic reactions (#metab)2
Prediction of binding to human serum albumin (QPlogKhsa)0.082
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)8.19
Number of nitrogen and oxygen atoms (#NandO)1
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q16853AOC3Amine oxidase, copper containingT69619SEA
P05067APPBeta amyloid A4 proteinT87024SEA
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
P15538CYP11B1Cytochrome P450 11B1T84621SEA
Q7Z2W7TRPM8Transient receptor potential cation channel subfamily M member 8T41955SEA
P09917ALOX5Arachidonate 5-lipoxygenaseT00140SEA
Q6P179ERAP2Endoplasmic reticulum aminopeptidase 2T65818SEA
P43119PTGIRProstanoid IP receptorT99954SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
P10636MAPTMicrotubule-associated protein tauT45593SEA
Q16236NFE2L2Nuclear factor erythroid 2-related factor 2T88505SEA
Q9H4B7TUBB1Tubulin beta-1 chainT84397SEA
Q7RTX1TAS1R1Taste receptorT41263SEA
P10323ACRAcrosinT24595SEA
Q96HK3CALMCalmodulinT39610SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T69619DI0190Hypertension[ICD-11: BA00-BA04]Q16853AOC3
T87024DI0025Alzheimer disease[ICD-11: 8A20]P05067APP
T87024DI0122Diagnostic imaging[ICD-11: N.A.]P05067APP
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T84621DI0062Breast cancer[ICD-11: 2C60-2C6Y]P15538CYP11B1
T84621DI0108Cushing syndrome[ICD-11: 5A70]P15538CYP11B1
T41955DI0422Upper respiratory tract disorder[ICD-11: CA0Z]Q7Z2W7TRPM8
T00140DI0037Asthma[ICD-11: CA23]P09917ALOX5
T00140DI0147Filariasis[ICD-11: 1F66]P09917ALOX5
T00140DI0403Thrombocytopenia[ICD-11: 3B64]P09917ALOX5
T99954DI0003Abortion[ICD-11: JA00]P43119PTGIR
T99954DI0102Coronary atherosclerosis[ICD-11: BA52]P43119PTGIR
T99954DI0356Pulmonary hypertension[ICD-11: BB01]P43119PTGIR
T45593DI0012Acute myeloid leukaemia[ICD-11: 2A60]P10636MAPT
T45593DI0025Alzheimer disease[ICD-11: 8A20]P10636MAPT
T45593DI0265Mild neurocognitive disorder[ICD-11: 6D71]P10636MAPT
T88505DI0038Ataxic disorder[ICD-11: 8A03]Q16236NFE2L2
T84397DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q9H4B7TUBB1
T41263DI0078Cholera[ICD-11: 1A00]Q7RTX1TAS1R1
T39610DI0068Cardiac arrhythmia[ICD-11: BC9Z]Q96HK3CALM
T39610DI0243Malaria[ICD-11: 1F40-1F45]Q96HK3CALM
T39610DI0370Schizophrenia[ICD-11: 6A20]Q96HK3CALM

Copyright © 2025